Skip to main content
Top
Published in: Langenbeck's Archives of Surgery 7/2020

Open Access 01-11-2020 | Pancreatic Surgery | Systematic Reviews and Meta-analyses

Systematic review and meta-analysis of contemporary pancreas surgery with arterial resection

Authors: Artur Rebelo, Ibrahim Büdeyri, Max Heckler, Jumber Partsakhashvili, Jörg Ukkat, Ulrich Ronellenfitsch, Christoph W. Michalski, Jörg Kleeff

Published in: Langenbeck's Archives of Surgery | Issue 7/2020

Login to get access

Abstract

Objective

Advances in multimodality treatment paralleled increasing numbers of complex pancreatic procedures with major vascular resections. The aim of this meta-analysis was to evaluate the current outcomes of arterial resection (AR) in pancreatic surgery.

Methods

A systematic literature search was carried out from January 2011 until January 2020. MOOSE guidelines were followed. Predefined outcomes were morbidity, pancreatic fistula, postoperative bleeding and delayed gastric emptying, reoperation rate, mortality, hospital stay, R0 resection rate, and lymph node positivity. Duration of surgery, blood loss, and survival were also analyzed.

Results

Eight hundred and forty-one AR patients were identified in a cohort of 7111 patients. Morbidity and mortality rates in these patients were 66.8% and 5.3%, respectively. Seven studies (579 AR patients) were included in the meta-analysis. Overall morbidity (48% vs 39%, p = 0.1) and mortality (3.2% vs 1.5%, p = 0.27) were not significantly different in the groups with or without AR. R0 was less frequent in the AR group, both in patients without (69% vs 89%, p < 0.001) and with neoadjuvant treatment (50% vs 86%, p < 0.001). Weighted median survival was shorter in the AR group (18.6 vs 32 months, range 14.8–43.1 months, p = 0.037).

Conclusions

Arterial resections increase the complexity of pancreatic surgery, as demonstrated by relevant morbidity and mortality rates. Careful patient selection and multidisciplinary planning remain important.
Appendix
Available only for authorised users
Literature
1.
go back to reference Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW et al (2017) Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 15(8):1028–1061 Tempero MA, Malafa MP, Al-Hawary M, Asbun H, Bain A, Behrman SW et al (2017) Pancreatic adenocarcinoma, version 2.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw 15(8):1028–1061
3.
go back to reference Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Buchler MW et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254(6):882–893PubMed Mollberg N, Rahbari NN, Koch M, Hartwig W, Hoeger Y, Buchler MW et al (2011) Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis. Ann Surg 254(6):882–893PubMed
4.
go back to reference Ghaneh, P., Palmer, D. H., Cicconi, S., Halloran, C., Psarelli, E. E., Rawcliffe, C. L., … Neoptolemos, J. P. (2020). ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer. J Clin Oncol, 38(15_suppl), 4505. https://doi.org/10.1200/JCO.2020.38.15_suppl.4505CrossRef Ghaneh, P., Palmer, D. H., Cicconi, S., Halloran, C., Psarelli, E. E., Rawcliffe, C. L., … Neoptolemos, J. P. (2020). ESPAC-5F: Four-arm, prospective, multicenter, international randomized phase II trial of immediate surgery compared with neoadjuvant gemcitabine plus capecitabine (GEMCAP) or FOLFIRINOX or chemoradiotherapy (CRT) in patients with borderline resectable pancreatic cancer. J Clin Oncol, 38(15_suppl), 4505. https://​doi.​org/​10.​1200/​JCO.​2020.​38.​15_​suppl.​4505CrossRef
5.
go back to reference van Tienhoven G, Versteijne E, Suker M, Groothuis KBC, Busch OR, Bonsing BA et al (2018) Preoperative chemoradiotherapy potentially improves outcome for (borderline) resectable pancreatic cancer: preliminary results of the Dutch randomized phase III PREOPANC trial. Int J Radiat Oncol Biol Phys 102:1606–1167 van Tienhoven G, Versteijne E, Suker M, Groothuis KBC, Busch OR, Bonsing BA et al (2018) Preoperative chemoradiotherapy potentially improves outcome for (borderline) resectable pancreatic cancer: preliminary results of the Dutch randomized phase III PREOPANC trial. Int J Radiat Oncol Biol Phys 102:1606–1167
6.
go back to reference Malleo G, Maggino L, Marchegiani G, Feriani G, Esposito A, Landoni L et al (2017) Pancreatectomy with venous resection for pT3 head adenocarcinoma: perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration. Pancreatology 17:847–857PubMed Malleo G, Maggino L, Marchegiani G, Feriani G, Esposito A, Landoni L et al (2017) Pancreatectomy with venous resection for pT3 head adenocarcinoma: perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration. Pancreatology 17:847–857PubMed
7.
go back to reference Kleive D, Sahakyan MA, Berstad AE, Verbeke CS, Gladhaug IP, Edwin B et al (2017) Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy. Br J Surg 104:1558–1567PubMed Kleive D, Sahakyan MA, Berstad AE, Verbeke CS, Gladhaug IP, Edwin B et al (2017) Trends in indications, complications and outcomes for venous resection during pancreatoduodenectomy. Br J Surg 104:1558–1567PubMed
8.
go back to reference Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283(15):2008–2012PubMed Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA. 283(15):2008–2012PubMed
10.
go back to reference Desaki R, Mizuno S, Tanemura A et al (2014) A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma ofthe pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy. Biomed Res Int 2014:219038PubMedPubMedCentral Desaki R, Mizuno S, Tanemura A et al (2014) A new surgical technique of pancreaticoduodenectomy with splenic artery resection for ductal adenocarcinoma ofthe pancreatic head and/or body invading splenic artery: impact of the balance between surgical radicality and QOL to avoid total pancreatectomy. Biomed Res Int 2014:219038PubMedPubMedCentral
11.
go back to reference Bockhorn M, Burdelski C, Bogoevski D et al (2011) Arterial en bloc resection for pancreatic carcinoma. Br J Surg 98:86–92PubMed Bockhorn M, Burdelski C, Bogoevski D et al (2011) Arterial en bloc resection for pancreatic carcinoma. Br J Surg 98:86–92PubMed
12.
go back to reference Klompmaker S, de Rooij T, Korteweg JJ, van Dieren S, van Lienden KP, van Gulik TM et al (2016) Systematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancer. BJS. 103(8):941–949 Klompmaker S, de Rooij T, Korteweg JJ, van Dieren S, van Lienden KP, van Gulik TM et al (2016) Systematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancer. BJS. 103(8):941–949
13.
go back to reference Klompmaker S, van Hilst J, Gerritsen SL, Adham M, Quer MTA, Bassi C et al (2018) Outcomes after distal pancreatectomy with celiac axis resection for pancreatic cancer: a pan-European retrospective cohort study. Ann Surg Oncol 25(5):1440–1447PubMedPubMedCentral Klompmaker S, van Hilst J, Gerritsen SL, Adham M, Quer MTA, Bassi C et al (2018) Outcomes after distal pancreatectomy with celiac axis resection for pancreatic cancer: a pan-European retrospective cohort study. Ann Surg Oncol 25(5):1440–1447PubMedPubMedCentral
14.
go back to reference Addeo P, Rosso E, Fuchshuber P, Oussoultzoglou E, De Blasi V, Simone G et al (2015) Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy. Oncology. 89(1):37–46.17PubMed Addeo P, Rosso E, Fuchshuber P, Oussoultzoglou E, De Blasi V, Simone G et al (2015) Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy. Oncology. 89(1):37–46.17PubMed
15.
go back to reference Amano R, Kimura K, Nakata B, Yamazoe S, Motomura H, Yamamoto A et al (2015) Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer. Surgery. 158(1):191–200PubMed Amano R, Kimura K, Nakata B, Yamazoe S, Motomura H, Yamamoto A et al (2015) Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer. Surgery. 158(1):191–200PubMed
16.
go back to reference Bachellier P, Addeo P, Faitot F, Nappo G, Dufour P (2018) Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience With 118 Patients. Ann Surg Bachellier P, Addeo P, Faitot F, Nappo G, Dufour P (2018) Pancreatectomy With Arterial Resection for Pancreatic Adenocarcinoma: How Can It Be Done Safely and With Which Outcomes?: A Single Institution's Experience With 118 Patients. Ann Surg
17.
go back to reference Baumgartner JM, Krasinskas A, Daouadi M, Zureikat A, Marsh W, Lee K et al (2012) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg 16(6):1152–1159PubMed Baumgartner JM, Krasinskas A, Daouadi M, Zureikat A, Marsh W, Lee K et al (2012) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic adenocarcinoma following neoadjuvant therapy. J Gastrointest Surg 16(6):1152–1159PubMed
18.
go back to reference Beane JD, House MG, Pitt SC, Kilbane EM, Hall BL, Parmar AD et al (2015) Distal pancreatectomy with celiac axis resection: what are the added risks? HPB (Oxford) 17(9):777–7784 Beane JD, House MG, Pitt SC, Kilbane EM, Hall BL, Parmar AD et al (2015) Distal pancreatectomy with celiac axis resection: what are the added risks? HPB (Oxford) 17(9):777–7784
19.
go back to reference Cesaretti M, Abdel-Rehim M, Barbier L, Dokmak S, Hammel P, Sauvanet A (2016) Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients. J Visc Surg 153(3):173–181PubMed Cesaretti M, Abdel-Rehim M, Barbier L, Dokmak S, Hammel P, Sauvanet A (2016) Modified Appleby procedure for borderline resectable/locally advanced distal pancreatic adenocarcinoma: A major procedure for selected patients. J Visc Surg 153(3):173–181PubMed
20.
go back to reference Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B et al (2014) Arterial resection at the time of pancreatectomy for cancer. Surgery. 155(5):919–926PubMed Christians KK, Pilgrim CH, Tsai S, Ritch P, George B, Erickson B et al (2014) Arterial resection at the time of pancreatectomy for cancer. Surgery. 155(5):919–926PubMed
22.
go back to reference Glebova NO, Hicks CW, Tosoian JJ, Piazza KM, Abularrage CJ, Schulick RD et al (2016) Outcomes of arterial resection during pancreatectomy for tumor. J Vasc Surg 63(3):722–729 e1PubMed Glebova NO, Hicks CW, Tosoian JJ, Piazza KM, Abularrage CJ, Schulick RD et al (2016) Outcomes of arterial resection during pancreatectomy for tumor. J Vasc Surg 63(3):722–729 e1PubMed
23.
go back to reference Ham H, Kim SG, Kwon HJ, Ha H, Choi YY (2015) Distal pancreatectomy with celiac axis resection for pancreatic body and tail cancer invading celiac axis. Ann Surg Treat Res 89(4):167–175PubMedPubMedCentral Ham H, Kim SG, Kwon HJ, Ha H, Choi YY (2015) Distal pancreatectomy with celiac axis resection for pancreatic body and tail cancer invading celiac axis. Ann Surg Treat Res 89(4):167–175PubMedPubMedCentral
24.
go back to reference Jing W, Zhu G, Hu X, Jing G, Shao C, Zhou Y et al (2013) Distal pancreatectomy with en bloc celiac axis resection for the treatment of locally advanced pancreatic body and tail cancer. Hepatogastroenterology. 60(121):187–190PubMed Jing W, Zhu G, Hu X, Jing G, Shao C, Zhou Y et al (2013) Distal pancreatectomy with en bloc celiac axis resection for the treatment of locally advanced pancreatic body and tail cancer. Hepatogastroenterology. 60(121):187–190PubMed
25.
go back to reference Loveday BPT, Zilbert N, Serrano PE, Tomiyama K, Tremblay A, Fox AM et al (2019) Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas. HPB (Oxford) 21(6):643–652 Loveday BPT, Zilbert N, Serrano PE, Tomiyama K, Tremblay A, Fox AM et al (2019) Neoadjuvant therapy and major arterial resection for potentially reconstructable arterial involvement by stage 3 adenocarcinoma of the pancreas. HPB (Oxford) 21(6):643–652
26.
go back to reference Miura T, Hirano S, Nakamura T, Tanaka E, Shichinohe T, Tsuchikawa T et al (2014) A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study. Surgery. 155(3):457–467PubMed Miura T, Hirano S, Nakamura T, Tanaka E, Shichinohe T, Tsuchikawa T et al (2014) A new preoperative prognostic scoring system to predict prognosis in patients with locally advanced pancreatic body cancer who undergo distal pancreatectomy with en bloc celiac axis resection: a retrospective cohort study. Surgery. 155(3):457–467PubMed
27.
go back to reference Miyazaki M, Yoshitomi H, Takano S, Shimizu H, Kato A, Yoshidome H et al (2017) Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer. Langenbeck's Arch Surg 402(3):447–456 Miyazaki M, Yoshitomi H, Takano S, Shimizu H, Kato A, Yoshidome H et al (2017) Combined hepatic arterial resection in pancreatic resections for locally advanced pancreatic cancer. Langenbeck's Arch Surg 402(3):447–456
28.
go back to reference Nakamura T, Hirano S, Noji T, Asano T, Okamura K, Tsuchikawa T et al (2016) Distal Pancreatectomy with en Bloc Celiac Axis Resection (Modified Appleby Procedure) for Locally Advanced Pancreatic Body Cancer: A Single-Center Review of 80 Consecutive Patients. Ann Surg Oncol 23(Suppl 5):969–975PubMed Nakamura T, Hirano S, Noji T, Asano T, Okamura K, Tsuchikawa T et al (2016) Distal Pancreatectomy with en Bloc Celiac Axis Resection (Modified Appleby Procedure) for Locally Advanced Pancreatic Body Cancer: A Single-Center Review of 80 Consecutive Patients. Ann Surg Oncol 23(Suppl 5):969–975PubMed
29.
go back to reference Ocuin LM, Miller-Ocuin JL, Novak SM, Bartlett DL, Marsh JW, Tsung A et al (2016) Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival. HPB (Oxford) 18(10):835–842 Ocuin LM, Miller-Ocuin JL, Novak SM, Bartlett DL, Marsh JW, Tsung A et al (2016) Robotic and open distal pancreatectomy with celiac axis resection for locally advanced pancreatic body tumors: a single institutional assessment of perioperative outcomes and survival. HPB (Oxford) 18(10):835–842
30.
go back to reference Okada K, Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A et al (2013) Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery. 153(3):365–372PubMed Okada K, Kawai M, Tani M, Hirono S, Miyazawa M, Shimizu A et al (2013) Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection? Surgery. 153(3):365–372PubMed
31.
go back to reference Perinel J, Nappo G, El Bechwaty M, Walter T, Hervieu V, Valette PJ et al (2016) Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement. Langenbeck's Arch Surg 401(8):1131–1142 Perinel J, Nappo G, El Bechwaty M, Walter T, Hervieu V, Valette PJ et al (2016) Locally advanced pancreatic duct adenocarcinoma: pancreatectomy with planned arterial resection based on axial arterial encasement. Langenbeck's Arch Surg 401(8):1131–1142
32.
go back to reference Peters NA, Javed AA, Cameron JL, Makary MA, Hirose K, Pawlik TM et al (2016) Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach? Ann Surg Oncol 23(11):3757–3764PubMed Peters NA, Javed AA, Cameron JL, Makary MA, Hirose K, Pawlik TM et al (2016) Modified Appleby Procedure for Pancreatic Adenocarcinoma: Does Improved Neoadjuvant Therapy Warrant Such an Aggressive Approach? Ann Surg Oncol 23(11):3757–3764PubMed
33.
go back to reference Rehders A, Stoecklein NH, Guray A, Riediger R, Alexander A, Knoefel WT (2012) Vascular invasion in pancreatic cancer: tumor biology or tumor topography? Surgery. 152(3 Suppl 1):S143–S151PubMed Rehders A, Stoecklein NH, Guray A, Riediger R, Alexander A, Knoefel WT (2012) Vascular invasion in pancreatic cancer: tumor biology or tumor topography? Surgery. 152(3 Suppl 1):S143–S151PubMed
34.
go back to reference Sakuraba M, Miyamoto S, Nagamatsu S, Kayano S, Taji M, Kinoshita T et al (2012) Hepatic artery reconstruction following ablative surgery for hepatobiliary and pancreatic malignancies. Eur J Surg Oncol 38(7):580–585 Sakuraba M, Miyamoto S, Nagamatsu S, Kayano S, Taji M, Kinoshita T et al (2012) Hepatic artery reconstruction following ablative surgery for hepatobiliary and pancreatic malignancies. Eur J Surg Oncol 38(7):580–585
35.
go back to reference Sato T, Saiura A, Inoue Y, Takahashi Y, Arita J, Takemura N (2016) Distal Pancreatectomy with En Bloc Resection of the Celiac Axis with Preservation or Reconstruction of the Left Gastric Artery in Patients with Pancreatic Body Cancer. World J Surg 40(9):2245–2253PubMed Sato T, Saiura A, Inoue Y, Takahashi Y, Arita J, Takemura N (2016) Distal Pancreatectomy with En Bloc Resection of the Celiac Axis with Preservation or Reconstruction of the Left Gastric Artery in Patients with Pancreatic Body Cancer. World J Surg 40(9):2245–2253PubMed
36.
go back to reference Sugiura T, Okamura Y, Ito T, Yamamoto Y, Uesaka K (2017) Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer. World J Surg 41(1):258–266PubMed Sugiura T, Okamura Y, Ito T, Yamamoto Y, Uesaka K (2017) Surgical Indications of Distal Pancreatectomy with Celiac Axis Resection for Pancreatic Body/Tail Cancer. World J Surg 41(1):258–266PubMed
37.
go back to reference Takahashi Y, Kaneoka Y, Maeda A, Isogai M (2011) Distal Pancreatectomy with Celiac Axis Resection for Carcinoma of the Body and Tail of the Pancreas. World J Surg 35(11):2535–2542PubMed Takahashi Y, Kaneoka Y, Maeda A, Isogai M (2011) Distal Pancreatectomy with Celiac Axis Resection for Carcinoma of the Body and Tail of the Pancreas. World J Surg 35(11):2535–2542PubMed
38.
go back to reference Tanaka E, Hirano S, Tsuchikawa T, Kato K, Matsumoto J, Shichinohe T (2012) Important technical remarks on distal pancreatectomy with en-bloc celiac axis resection for locally advanced pancreatic body cancer (with video). J Hepatobiliary Pancreat Sci 19(2):141–147PubMed Tanaka E, Hirano S, Tsuchikawa T, Kato K, Matsumoto J, Shichinohe T (2012) Important technical remarks on distal pancreatectomy with en-bloc celiac axis resection for locally advanced pancreatic body cancer (with video). J Hepatobiliary Pancreat Sci 19(2):141–147PubMed
39.
go back to reference Tee MC, Krajewski AC, Groeschl RT, Farnell MB, Nagorney DM, Kendrick ML et al (2018) Indications and Perioperative Outcomes for Pancreatectomy with Arterial Resection. J Am Coll Surg 227(2):255–269PubMed Tee MC, Krajewski AC, Groeschl RT, Farnell MB, Nagorney DM, Kendrick ML et al (2018) Indications and Perioperative Outcomes for Pancreatectomy with Arterial Resection. J Am Coll Surg 227(2):255–269PubMed
40.
go back to reference Ueda A, Sakai N, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S et al (2019) Is hepatic artery coil embolization useful in distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic cancer? World J Surg Oncol 17(1):124PubMedPubMedCentral Ueda A, Sakai N, Yoshitomi H, Furukawa K, Takayashiki T, Kuboki S et al (2019) Is hepatic artery coil embolization useful in distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic cancer? World J Surg Oncol 17(1):124PubMedPubMedCentral
41.
go back to reference Wang X, Dong Y, Jin J, Liu Q, Zhan Q, Chen H et al (2015) Efficacy of modified Appleby surgery: a benefit for elderly patients? J Surg Res 194(1):83–90PubMed Wang X, Dong Y, Jin J, Liu Q, Zhan Q, Chen H et al (2015) Efficacy of modified Appleby surgery: a benefit for elderly patients? J Surg Res 194(1):83–90PubMed
42.
go back to reference Yamamoto Y, Sakamoto Y, Ban D, Shimada K, Esaki M, Nara S et al (2012) Is celiac axis resection justified for T4 pancreatic body cancer? Surgery. 151(1):61–69PubMed Yamamoto Y, Sakamoto Y, Ban D, Shimada K, Esaki M, Nara S et al (2012) Is celiac axis resection justified for T4 pancreatic body cancer? Surgery. 151(1):61–69PubMed
43.
go back to reference Yoshitomi H, Sakai N, Kagawa S, Takano S, Ueda A, Kato A et al (2019) Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer. Langenbeck's Arch Surg 404(4):451–458 Yoshitomi H, Sakai N, Kagawa S, Takano S, Ueda A, Kato A et al (2019) Feasibility and safety of distal pancreatectomy with en bloc celiac axis resection (DP-CAR) combined with neoadjuvant therapy for borderline resectable and unresectable pancreatic body/tail cancer. Langenbeck's Arch Surg 404(4):451–458
44.
go back to reference Zhou YM, Zhang XF, Li XD, Liu XB, Wu LP, Li B (2014) Distal pancreatectomy with en bloc celiac axis resection for pancreatic body-tail cancer: Is it justified? Med Sci Monit 20:1–5PubMedPubMedCentral Zhou YM, Zhang XF, Li XD, Liu XB, Wu LP, Li B (2014) Distal pancreatectomy with en bloc celiac axis resection for pancreatic body-tail cancer: Is it justified? Med Sci Monit 20:1–5PubMedPubMedCentral
46.
go back to reference Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 142(5):761–768PubMed Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR et al (2007) Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery. 142(5):761–768PubMed
48.
go back to reference Campbell, F., Foulis, A., & Verbeke, C. (2010). Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct May 2010, (261035), 1–27. Campbell, F., Foulis, A., & Verbeke, C. (2010). Dataset for the histopathological reporting of carcinomas of the pancreas, ampulla of Vater and common bile duct May 2010, (261035), 1–27.
49.
go back to reference Sterne JAC, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JPT (2016) ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ Sterne JAC, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I, Carpenter JR, Chan AW, Churchill R, Deeks JJ, Hróbjartsson A, Kirkham J, Jüni P, Loke YK, Pigott TD, Ramsay CR, Regidor D, Rothstein HR, Sandhu L, Santaguida PL, Schünemann HJ, Shea B, Shrier I, Tugwell P, Turner L, Valentine JC, Waddington H, Waters E, Wells GA, Whiting PF, Higgins JPT (2016) ROBINS-I: a tool for assessing risk of bias in non-randomized studies of interventions. BMJ
50.
go back to reference Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedPubMedCentral Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213PubMedPubMedCentral
51.
go back to reference Green S, Higgins J, Alderson P, Clarke M, Mulrow C, Oxman A (2008) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons Ltd., West Sussex, England Green S, Higgins J, Alderson P, Clarke M, Mulrow C, Oxman A (2008) Cochrane handbook for systematic reviews of interventions. John Wiley & Sons Ltd., West Sussex, England
52.
go back to reference Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13PubMedPubMedCentral Hozo SP, Djulbegovic B, Hozo I (2005) Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol 5:13PubMedPubMedCentral
55.
go back to reference Keck T, Wellner UF, Bahra M, Klein F, Sick O, Niedergethmann M,…Hopt UT (2016) Pancreatogastrostomy versus pancreatojejunostomy for reconstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and long-term results of a multicenter randomized controlled trial. Ann Surg, 263(3), 440–449. https://doi.org/10.1097/SLA.0000000000001240 Keck T, Wellner UF, Bahra M, Klein F, Sick O, Niedergethmann M,…Hopt UT (2016) Pancreatogastrostomy versus pancreatojejunostomy for reconstruction after PANCreatoduodenectomy (RECOPANC, DRKS 00000767): Perioperative and long-term results of a multicenter randomized controlled trial. Ann Surg, 263(3), 440–449. https://​doi.​org/​10.​1097/​SLA.​0000000000001240​
56.
go back to reference Kurtoglu M, Schlitter AM, Goklemez S, Budeyri I, Tesfay T, Gurses B et al (2016) Obstructive pancreatitis is a stronger fibrogenic stimulus than cancer-specific stellate cell activation in pancreatic ductal adenocarcinoma. Pancreatology. 3(16):S36–SS7 Kurtoglu M, Schlitter AM, Goklemez S, Budeyri I, Tesfay T, Gurses B et al (2016) Obstructive pancreatitis is a stronger fibrogenic stimulus than cancer-specific stellate cell activation in pancreatic ductal adenocarcinoma. Pancreatology. 3(16):S36–SS7
57.
go back to reference Gong H, Ma R, Gong J, Cai C, Song Z, Xu B (2016) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic cancer: a systematic review and meta-analysis. Medicine. 95(10) Gong H, Ma R, Gong J, Cai C, Song Z, Xu B (2016) Distal pancreatectomy with en bloc celiac axis resection for locally advanced pancreatic cancer: a systematic review and meta-analysis. Medicine. 95(10)
58.
go back to reference Latenstein, A. E. J., van der Geest, L. G. M., Bonsing, B. A., Groot Koerkamp, B., Haj Mohammad, N., de Hingh, I. H. J. T., … Wilmink, J. W. (2020). Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer, 125, 83–93.PubMed Latenstein, A. E. J., van der Geest, L. G. M., Bonsing, B. A., Groot Koerkamp, B., Haj Mohammad, N., de Hingh, I. H. J. T., … Wilmink, J. W. (2020). Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma. Eur J Cancer, 125, 83–93.PubMed
59.
go back to reference Kluger MD, Rashid MF, Rosario VL, Schrope BA, Steinman JA, Hecht EM et al (2018) Resection of locally advanced pancreatic cancer without regression of arterial encasement after modern-era neoadjuvant therapy. J Gastrointest Surg 22(2):235–241PubMed Kluger MD, Rashid MF, Rosario VL, Schrope BA, Steinman JA, Hecht EM et al (2018) Resection of locally advanced pancreatic cancer without regression of arterial encasement after modern-era neoadjuvant therapy. J Gastrointest Surg 22(2):235–241PubMed
60.
go back to reference Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P et al (2016) Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 Randomized Clinical Trial. Jama 315(17):1844–1853PubMed Hammel P, Huguet F, van Laethem JL, Goldstein D, Glimelius B, Artru P et al (2016) Effect of chemoradiotherapy vs chemotherapy on survival in patients with locally advanced pancreatic cancer controlled after 4 months of gemcitabine with or without erlotinib: the LAP07 Randomized Clinical Trial. Jama 315(17):1844–1853PubMed
61.
go back to reference Suker M, Nuyttens JJ, Eskens FALM, Haberkorn BCM, Coene PPLO, van der Harst E et al (2019) Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial). EClin Med 17(C):100200 Suker M, Nuyttens JJ, Eskens FALM, Haberkorn BCM, Coene PPLO, van der Harst E et al (2019) Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial). EClin Med 17(C):100200
62.
go back to reference Vidri RJ, Vogt AO, Macgillivray DC, Bristol IJ, Fitzgerald TL (2019) Better defining the role of total neoadjuvant radiation: changing paradigms in locally advanced pancreatic cancer. Ann Surg Oncol 26(11):3701–3708PubMed Vidri RJ, Vogt AO, Macgillivray DC, Bristol IJ, Fitzgerald TL (2019) Better defining the role of total neoadjuvant radiation: changing paradigms in locally advanced pancreatic cancer. Ann Surg Oncol 26(11):3701–3708PubMed
63.
go back to reference Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon J (2005) Meta-analysis when only the median survival times are known: A comparison with individual patient data results. Int J Technol Assess Health Care 21(1):119–125PubMed Michiels S, Piedbois P, Burdett S, Syz N, Stewart L, Pignon J (2005) Meta-analysis when only the median survival times are known: A comparison with individual patient data results. Int J Technol Assess Health Care 21(1):119–125PubMed
Metadata
Title
Systematic review and meta-analysis of contemporary pancreas surgery with arterial resection
Authors
Artur Rebelo
Ibrahim Büdeyri
Max Heckler
Jumber Partsakhashvili
Jörg Ukkat
Ulrich Ronellenfitsch
Christoph W. Michalski
Jörg Kleeff
Publication date
01-11-2020
Publisher
Springer Berlin Heidelberg
Published in
Langenbeck's Archives of Surgery / Issue 7/2020
Print ISSN: 1435-2443
Electronic ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-020-01972-2

Other articles of this Issue 7/2020

Langenbeck's Archives of Surgery 7/2020 Go to the issue